Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer
Open Access
- 1 November 1998
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (10), 1323-1328
- https://doi.org/10.1038/bjc.1998.678
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trialThe Lancet, 1997
- The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1996
- A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: An interim toxicity analysis of the first 100 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Interruptions of high-dose radiation therapy decrease longterm survival of favorable patients with unresectable nonsmall cell carcinoma of the lung: analysis of 1244 cases from 3 radiation therapy oncology group (RTOG) trialsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapyRadiotherapy and Oncology, 1992
- Assessment of Human Tumour Proliferation Using Bromodeoxyuridine—Current StatusActa Oncologica, 1991
- A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.Journal of Clinical Oncology, 1990
- The recording of morbidity related to radiotherapyRadiotherapy and Oncology, 1989
- Primary tumor control after radiotherapy for carcinoma of the bronchusInternational Journal of Radiation Oncology*Biology*Physics, 1984
- A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchusInternational Journal of Radiation Oncology*Biology*Physics, 1982